Eli Lilly & Co. (LLY): Price and Financial Metrics


Eli Lilly & Co. (LLY): $360.99

-10.80 (-2.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LLY POWR Grades

  • LLY scores best on the Quality dimension, with a Quality rank ahead of 92.17% of US stocks.
  • LLY's strongest trending metric is Stability; it's been moving down over the last 26 weeks.
  • LLY's current lowest rank is in the Momentum metric (where it is better than 10.86% of US stocks).

LLY Stock Summary

  • LLY has a higher market value than 99.67% of US stocks; more precisely, its current market capitalization is $350,178,563,266.
  • LLY's went public 36.96 years ago, making it older than 93.52% of listed US stocks we're tracking.
  • With a price/sales ratio of 11.98, ELI LILLY & CO has a higher such ratio than 91.09% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to ELI LILLY & CO are PFE, MRK, ABBV, NVO, and TSM.
  • LLY's SEC filings can be seen here. And to visit ELI LILLY & CO's official web site, go to www.lilly.com.

LLY Valuation Summary

  • In comparison to the median Healthcare stock, LLY's price/earnings ratio is 151.95% higher, now standing at 58.2.
  • Over the past 243 months, LLY's price/earnings ratio has gone up 29.2.

Below are key valuation metrics over time for LLY.

Stock Date P/S P/B P/E EV/EBIT
LLY 2022-12-05 12.0 34.8 58.2 55.6
LLY 2022-12-02 12.2 35.4 59.0 56.4
LLY 2022-12-01 12.0 34.9 58.3 55.7
LLY 2022-11-30 12.1 35.0 58.4 55.9
LLY 2022-11-29 11.8 34.3 57.3 54.8
LLY 2022-11-28 11.9 34.5 57.6 55.1

LLY Growth Metrics

    The year over year price growth rate now stands at 59.83%.
  • Its 5 year net income to common stockholders growth rate is now at 102.12%.
  • The 2 year revenue growth rate now stands at 27.01%.
Over the past 33 months, LLY's revenue has gone up $6,920,000,000.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 29,239.5 7,661.2 6,033.2
2022-06-30 29,070.7 7,107.7 5,691.6
2022-03-31 29,322.8 8,062.5 6,129.3
2021-12-31 28,318.4 7,260.7 5,581.7
2021-09-30 27,758.5 6,919.4 5,972.4
2021-06-30 26,726.3 7,094.7 6,070.7

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LLY has a Quality Grade of B, ranking ahead of 90.11% of graded US stocks.
  • LLY's asset turnover comes in at 0.586 -- ranking 60th of 681 Pharmaceutical Products stocks.
  • BHC, VRTX, and DRRX are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.586 0.748 0.191
2021-06-30 0.577 0.743 0.199
2021-03-31 0.568 0.759 0.203
2020-12-31 0.565 0.777 0.214
2020-09-30 0.558 0.783 0.198
2020-06-30 0.573 0.787 0.202

LLY Price Target

For more insight on analysts targets of LLY, see our LLY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $265.88 Average Broker Recommendation 1.5 (Moderate Buy)

LLY Stock Price Chart Interactive Chart >

Price chart for LLY

LLY Price/Volume Stats

Current price $360.99 52-week high $375.25
Prev. close $371.79 52-week low $231.87
Day low $360.81 Volume 2,787,100
Day high $374.00 Avg. volume 2,907,404
50-day MA $351.39 Dividend yield 1.05%
200-day MA $314.81 Market Cap 343.00B

Eli Lilly & Co. (LLY) Company Bio


Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. (Source:Wikipedia)


LLY Latest News Stream


Event/Time News Detail
Loading, please wait...

LLY Latest Social Stream


Loading social stream, please wait...

View Full LLY Social Stream

Latest LLY News From Around the Web

Below are the latest news stories about ELI LILLY & CO that investors may wish to consider to help them evaluate LLY as an investment opportunity.

Innovent''s drug shows promise in advanced lung cancer patients in early-stage trial

Innovent Biologics (IVBIY) (IVBXF) reported data from a phase 1b trial of IBI939 in combination with the company and Eli Lilly''s (LLY) Tyvyt (sintilimab) in patients with…

Seeking Alpha | December 9, 2022

How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

Investor''s Business Daily | December 9, 2022

Here''s What We Know So Far About Amgen''s Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Investor''s Business Daily | December 8, 2022

Eli Lilly tightens access to diabetes drug, frustrating some people with obesity

“It’s frustrating that I got teased with something that helped other things plus the weight loss, and now I can’t get it,” said a woman who had been taking the…

STAT News | December 7, 2022

LLY stock on watch as diabetes drug meets main goal in young patients (NYSE:LLY)

Eli Lilly (LLY) and Boehringer Ingelheim announced Wednesday that the Phase 3 trial for SGLT2 inhibitor Jardiance met the primary endpoint in young patients. Read the full story here.

Seeking Alpha | December 7, 2022

Read More 'LLY' Stories Here

LLY Price Returns

1-mo -1.82%
3-mo 13.94%
6-mo 24.68%
1-year 49.88%
3-year 213.73%
5-year 358.30%
YTD 32.48%
2021 66.08%
2020 31.04%
2019 16.14%
2018 40.45%
2017 17.83%

LLY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full LLY Dividend History

Continue Researching LLY

Want to see what other sources are saying about ELI LILLY & Co's financials and stock price? Try the links below:

ELI LILLY & Co (LLY) Stock Price | Nasdaq
ELI LILLY & Co (LLY) Stock Quote, History and News - Yahoo Finance
ELI LILLY & Co (LLY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8609 seconds.